Genetics of Breast Cancer

作者: Mark H. Greene

DOI: 10.4065/72.1.54

关键词: Risk factorPredictive testingBreast cancerOvarian cancerPopulationGeneticsMedicineCancerGenetic counselingGenetic testing

摘要: Familial breast cancer is characterized by young age at diagnosis, an increased risk of bilateral cancer, increasing in conjunction with numbers affected family members, and a strong association ovarian cancer. At least eight candidate susceptibility genes have been identified. Mutations BRCA1, BRCA2, p53, the Cowden disease gene are relatively uncommon, highly penetrant, produce striking familial clusters BRCA1 BRCA2 most important these, accounting for estimated 80% hereditary 5 to 6% all cancers. Specific mutations particular importance population subgroups, such as those identified among Jewish women central European (Ashkenazi) origin. ataxia-telangiectasia rare HRAS1 variable number tandem repeats polymorphisms much more common but also less penetrant. They do not dramatic aggregations may prove be responsible substantial proportion cancers if their epidemiologic confirmed. Predictive genetic testing under way. Oncologists primary-care physicians must become familiar these disorders issues surrounding predictive order make appropriate management decisions about thought high

参考文章(99)
Narod S, Tonin P, Simard J, Morgan K, Lenoir G, Serova O, Durocher F, Lynch H, BRCA1 mutations in Ashkenazi Jewish women. American Journal of Human Genetics. ,vol. 57, pp. 189- 189 ,(1995)
J. Wagner-Costalas, D. C. Schultz, M. Daly, D. B. Berman, H. T. Lynch, A. K. Godwin, Two distinct origins of a common BRCA1 mutation in breast-ovarian cancer families: A genetic study of 15 185delAG-mutation kindreds American Journal of Human Genetics. ,vol. 58, pp. 1166- 1176 ,(1996)
Ronald B. J. Glass, Kenneth N. Rosenbaum, Detection of eight BRCA1 mutations in 10 breast/ovarian cancer families, including 1 family with male breast cancer. American Journal of Human Genetics. ,vol. 57, pp. 1- 5 ,(1995) , 10.1002/AJMG.1320570102
S.A. Narod, J.E. Garber, S.A. Smith, P. Devilee, H.T. Lynch, B.A.J. Ponder, B.L. Weber, J.M. Birch, R.B. Barkardottir, D. Ford, An evaluation of genetic heterogeneity in 145 breast-ovarian cancer families. Breast Cancer Linkage Consortium. American Journal of Human Genetics. ,vol. 56, pp. 254- 264 ,(1995)
Patrick Dowd, Csilla I. Szabo, Lesley Butler, Sarah E. Rowell, Mary Claire King, Elizabeth A. Ostermeyer, Ming K. Lee, Tari Park, Lori S. Friedman, Ellen L. Goode, Novel inherited mutations and variable expressivity of BRCA1 alleles, including the founder mutation 185delAG in Ashkenazi Jewish families. American Journal of Human Genetics. ,vol. 57, pp. 1284- 1297 ,(1995)
R B Barkardottir, A Arason, G Johannesdottir, J Gudmundsson, J T Bergthorsson, S Ingvarsson, Egilsson, Frequent occurrence of BRCA2 linkage in Icelandic breast cancer families and segregation of a common BRCA2 haplotype American Journal of Human Genetics. ,vol. 58, pp. 749- 756 ,(1996)
Edward D. Lustbader, Sara Strom, Melissa L. Bondy, Louise C. Strong, Wick R. Williams, Segregation analysis of cancer in families of childhood soft-tissue-sarcoma patients. American Journal of Human Genetics. ,vol. 51, pp. 344- 356 ,(1992)
J Peto, D F Easton, D Ford, Estimates of the gene frequency of BRCA1 and its contribution to breast and ovarian cancer incidence. American Journal of Human Genetics. ,vol. 57, pp. 1457- 1462 ,(1995)
Louise A. Brinton, Catherine Schairer, Estrogen Replacement Therapy and Breast Cancer Risk Epidemiologic Reviews. ,vol. 15, pp. 66- 79 ,(1993) , 10.1093/OXFORDJOURNALS.EPIREV.A036117
Jonine L. Bernstein, W. Douglas Thompson, Neil Risch, Theodore R. Holford, The genetic epidemiology of second primary breast cancer American Journal of Epidemiology. ,vol. 136, pp. 937- 948 ,(1992) , 10.1093/OXFORDJOURNALS.AJE.A116566